Zavzpret (zavegepant nasal spray) — Medica

Initial criteria

• Patient is age ≥ 18 years
• Patient has tried at least one triptan therapy OR patient has a contraindication to triptan(s)

Reauthorization criteria

• Patient continues to meet initial criteria

Approval duration

1 year